How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective : Current Opinion in Neurology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
HEADACHE: Edited by Messoud Ashina and Henrik Winther Schytz

How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective

Torres-Ferrus, Martaa,b; Alpuente, Aliciaa,b; Pozo-Rosich, Patriciaa,b

Author Information
Current Opinion in Neurology: June 2019 - Volume 32 - Issue 3 - p 395-404
doi: 10.1097/WCO.0000000000000689
  • Buy

Abstract

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.